(Received for publication, January 30, 1997, and in revised form, February 18, 1997)
From the Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109
Recent studies have identified a number of cell death pathway components. In this study, we describe the role that two such components, Bik and Bak, play in initiating the apoptotic program. These Bcl-2 family members engage the death pathway downstream of the block imposed by the serpin CrmA, but upstream of the block initiated by cellular inhibitors of apoptosis, which are a family of molecules characterized by a conserved baculovirus inhibitor of apoptosis repeat motif. Distal death pathway components activated by Bik and Bak are similar to those activated by the CD-95 (Fas/Apo1) and tumor necrosis factor death receptors.
Apoptosis or programmed cell death plays a critical role in the survival of multicellular organisms. Unchecked, it can contribute to a number of degenerative conditions such as Alzheimer's disease (1, 2). Conversely, excessive inhibition of cell death can lead to the accumulation of abnormal cells that may become transformed or contribute to autoimmune disease (3). Therefore, preserving the balance between pro- and anti-apoptotic influences is essential for maintaining tissue homeostasis (4).
Genetic studies in Caenorhabditis elegans have contributed much to the understanding of key components of the cell death machinery by the identification of an inhibitor of apoptosis, ced-9, and two inducers of apoptosis, ced-3 and ced-4 (5). The ced-9 gene is homologous to the human bcl-2 gene, which is overexpressed in follicular lymphomas and contributes to a heightened state of resistance to cell death induced by a variety of agents including glucocorticoids and irradiation (6-9). Although the mammalian homologue of ced-4 has yet to be identified, CED-3 is homologous to a family of interleukin-1-converting enzyme-like proteases (ICE)1 recently renamed caspases (10, 11). Caspases are cysteine proteases that cleave substrates following aspartate residues and when overexpressed can induce apoptosis (12, 13). In addition, caspases are converted from an inactive zymogen form to a cleaved active dimeric species upon receipt of a death signal (14, 15).
Although the components identified in C. elegans have revealed some of the essential mammalian counterparts involved in apoptosis, additional complexity exists in mammalian systems. A number of receptors involved in immune function that contain death domains, including CD-95, tumor necrosis factor receptor-1 (TNFR1 or p55), and DR3/WSL-1, can engage the death pathway by using adapter molecules such as FADD/MORT1 to directly recruit a proximal caspase (caspase-8/FLICE/MACH) (16-25). Additionally, while there is only one ced-9 gene in C. elegans, there are a number of Bcl-2 homologues in mammals that can either suppress (Bcl-x) (26) or activate (Bax, Bik, Bak) (27-31) the apoptotic program. Superimposed on this are viral inhibitors of cell death that attenuate the pathway allowing for increased replication of viral progeny in infected host cells. The pox virus-encoded serpin, CrmA, preferentially inhibits proximal components of the ICE/CED-3 protease cascade, including caspase-8 (32, 33). In contrast, the baculoviral encoded gene product p35 interrupts the death pathway by inhibiting a broad spectrum of caspases (34, 35). Additional baculoviral gene products that inhibit apoptosis are the IAP molecules (Cp-IAP and Op-IAP) that are characterized by protein repeat (BIR) domains (36). While the exact mode of action of these inhibitors is unclear, homologues in Drosophila and humans have been identified (37-41). Remarkably, deficiency of one of the human IAP genes (NIAP) may contribute to the excessive neuronal apoptosis that characterizes spinal muscular atrophy (42, 43).
To gain a better understanding of how these different modulators and effectors of apoptosis might function, we investigated the activities of two activators of apoptosis, Bik and Bak, with respect to various inhibitors of the cell death program. Herein, we show that the activation of apoptosis by Bik and Bak occurs downstream of the CrmA block. However, a broad spectrum peptide inhibitor of the caspase family, z-VAD-fmk, attenuated cell death induced by Bik or Bak, implying a downstream effector role for caspases. Confirming this is the finding that caspase-7, a distal caspase, is processed to its active form upon induction of cell death by Bik or Bak. Surprisingly, the mammalian counterparts to the baculoviral IAPs (cIAP1 and cIAP2) inhibited Bik- and Bak-induced apoptosis. This allows for the derivation of a model that tentatively positions the aforementioned components in the apoptotic program.
MCF7, a human breast carcinoma cell line transfected with either vector (Neo-vector) or a CrmA expression construct (Neo-CrmA) (33) was maintained in RPMI containing 10% heat-inactivated fetal bovine serum. The HA-Bik and HA-Bak constructs were generously provided by G. Chinnadurai. The myc-IAP1 and myc-IAP2 constructs were generously provided by D. V. Goeddel. The p55 TNF receptor construct was described previously in Ref. 19.
Death AssaysThese were performed essentially as described
previously (44). Briefly, parental, Neo-vector or Neo-CrmA cells were
plated on a six-well tissue culture dish (2 × 105
cells/well) and transiently transfected with 100 ng of the reporter plasmid pCMV--galactosidase plus 0.2 µg of the test plasmid. Inhibition assays included 0.8 µg of the inhibitor test plasmid. Five
hours following transfection, 1 ml of complete medium (in the presence
or absence of 40 µM z-VAD-fmk) was added. Nonapoptotic or
apoptotic cells were detected by staining with
5-bromo-4-chloro-3-indolyl
-D-galactopyranoside as
described previously (44). Percent apoptotic cells represents the mean
value from two or more experiments (mean ± S.D.).
This was performed essentially as described previously (45). Transiently transfected 293 cells (~2 × 106 cells) were lysed in Buffer A (0.1% Nonidet P-40, 50 mM Hepes, pH 7.6, 50 mM KCl, 10 mM EGTA, 2 mM MgCl, 1 mM dithiothreitol plus protease inhibitors), clarified by centrifugation, and the supernatant resolved by SDS-polyacrylamide gel electrophoresis. After transfer to nitrocellulose, the filter was incubated with a 1:1000 dilution of the caspase-7 antibody followed by incubation with a 1:10,000 dilution of secondary goat anti-rabbit horseradish peroxidase conjugate (Amersham Corp.). Bound antibody was visualized using the ECL kit (Amersham) as per manufacturer's instructions. Poly(ADP-ribose) polymerase (PARP) was detected in urea/SDS-solubilized nuclei by immunoblotting as described previously (46).
CrmA is a virally encoded serpin that inhibits both CD-95 and TNF-induced cell death (33). It apparently functions at the apex of these receptor-initiated cell death pathways based on its ability to block the activation of a number of downstream caspases, including caspase-3 (YAMA, CPP32, apopain), caspase-6 (Mch2), and caspase-7 (ICE-LAP3, Mch3, CMH-1) (20, 24, 33, 47, 48). Therefore, the protease(s) that CrmA inhibits must be upstream of these distal caspases. Additionally, staurosporine can by-pass the proximal CrmA block and induce activation of these same distal caspases (47, 48). Finally, CrmA is a relatively weak inhibitor of the distal caspases (caspase-3, caspase-6, and caspase-7), whereas it is a potent inhibitor of caspase-8, which functions at the apex of the cascade (32, 49). Using the previously characterized MCF7 vector or CrmA stable transfectants, we investigated whether the proapoptotic members of the Bcl-2 family, Bik and Bak, could by-pass the upstream CrmA block.
As observed previously, TNF induced apoptosis in the vector control
cell line, whereas the CrmA cell line was protected (Fig. 1) (33). The vector control cell line transfected with
Bik or Bak underwent apoptosis. However, the CrmA-expressing cell line also underwent apoptosis with similar kinetics. Identical results were
observed when CrmA and Bik or Bak were transiently cotransfected into
the parental MCF7 cell line, implying that the result was not
attributable to clonal variation (data not shown). The gross morphology
of the apoptotic cells induced to die by either overexpression of Bik
or Bak or treatment with TNF was indistinguishable. Therefore, although
Bik and Bak must initially activate a distinct pathway from that
engaged by CD-95 or TNF (as revealed by CrmA sensitivity), downstream
of CrmA the pathways are likely to be similar.
Bik and Bak Activate Caspases to Induce Cell Death
In
vivo, caspases are potently inhibited by the cell permeable, broad
spectrum peptide inhibitor z-VAD-fmk (50, 51). This peptide inhibitor
abrogates both CD-95- and TNF-induced cell death (Fig.
2A) and attenuates a number of other forms of
death, including glucocorticoid-induced death (8, 9). Likewise, Bik-
and Bak-induced cell death was inhibited by z-VAD-fmk (Fig.
2A), consistent with death being mediated by caspase
activation.
To confirm this, the activation of one of the distal caspases, caspase-7, was examined. The caspases are found as single polypeptide zymogens in live cells, whereas upon receipt of a death signal (such as activation of CD-95 or TNF receptors or exposure to staurosporine) these proteases are processed into an active dimeric species (45, 47, 48). As shown in Fig. 2B, in mock-transfected cells (first lane) caspase 7 is present in its zymogen form, whereas in cells overexpressing the cytotoxic p55 TNF receptor (second lane) this caspase is converted to the active processed form as evidenced by the appearance of the large catalytic subunit (~20 kDa). Since Bik or Bak overexpression also resulted in the conversation of caspase-7 to its active form (Fig. 2B, third and fourth lanes, respectively), these proapoptotic Bcl-2 homologues must promote the activation of downstream caspases.
Finally, we analyzed the state of the endogenous apoptotic substrate, PARP (46). In nonapoptotic cells PARP is observed in the uncleaved form (116 kDa), whereas in apoptotic cells PARP is characteristically cleaved to an indicator apoptotic fragment (85 kDa) by a variety of active caspases (Fig. 2C, first and second lanes, respectively). As shown in Fig. 2C, cells transiently transfected with Bik (third lane) or Bak (fourth lane) contained this signature apoptotic PARP fragment that presumably was the result of cleavage by an activated endogenous caspase. This provides additional confirmation that Bik and Bak can by-pass the CrmA block and functionally activate downstream caspases.
IAPs Inhibit Bik- and Bak-induced Cell DeathBy contrast to
CrmA, the mammalian counterparts of the baculoviral IAP genes (cIAP1
and cIAP2) inhibited both Bik- and Bak-induced apoptosis. Cells
transiently cotransfected with Bik or Bak and either cIAP1 or cIAP2
(singly or together) did not undergo apoptosis (Fig. 3).
Since no physical association between Bik or Bak and the cIAPs was
observed (data not shown), it is likely that the effect involves an
intermediary molecule(s). Regardless, Bik and Bak engage the death
pathway upstream of the IAP block.
Molecular Ordering of Bik and Bak in the Apoptotic Pathway
Our results are consistent with a model whereby Bik and
Bak trigger apoptosis by activation of caspases distal to the CrmA block but upstream of the IAPs. Our studies, however, do not address the question of whether Bik and Bak act by directly engaging the death
machinery or by simply inhibiting an inhibitor of apoptosis such as
Bcl-2. Finally, Bik and Bak were shown to promote the activation of
distal caspases similar to those utilized by the CD-95 and TNF death
pathways (Fig. 4).
We are grateful to G. Chinnadurai and D. V. Goeddel for expression constructs. For technical help and helpful discussions, we thank C. Vincenz, E. Humke, K. O'Rourke, and D. R. Beidler. A special thanks to Ian Jones for his assistance with figures. K. O. appreciates the helpful advice from S. J. Orth.